Literature DB >> 20127856

Characterization of X-chromosome inactivation status in human pluripotent stem cells.

Jennifer A Erwin1, Jeannie T Lee.   

Abstract

This unit describes a method of performing fluorescent in situ hybridization (FISH) of XIST and Cot-1 RNA in human pluripotent stem cells (hPSC) to characterize the epigenetic status of X-chromosome inactivation (XCI). hPSC laboratories commonly practice karyotypic analysis to monitor genetic stability; however, epigenetic stability is often overlooked. Several laboratories have recently shown that markers of XCI can be used as one effective screen to monitor the epigenetic status of hPSCs. Human embryonic stem cells (HESC) fall into three classes of XCI states: upregulating XIST upon differentiation, always expressing XIST in the undifferentiated and differentiated states, and never expressing XIST in the undifferentiated and differentiated states. Failure to express XIST represents an especially concerning state in hESC, as this state does not occur in healthy female cells but is often seen in malignancies. Herein, methods of carrying out XIST RNA and Cot-1 RNA FISH are described. FISH analysis of XIST RNA, unlike general expression analysis such as RT-PCR, allows for the classification of XCI on a single-cell level, enabling a quantitative determination of the degree of epigenetic change across the population. The complementary Cot-1 analysis measures the extent of repeat element expression throughout the nucleus and therefore enables determination, at a cytological level, of the extent to which the X chromosome is silent. Because the different steps of XCI are some of the first epigenetic changes to take place in differentiating hESC, analysis of the XCI state provides a first indication of an hESC culture's overall health.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20127856      PMCID: PMC3741660          DOI: 10.1002/9780470151808.sc01b06s12

Source DB:  PubMed          Journal:  Curr Protoc Stem Cell Biol        ISSN: 1938-8969


  15 in total

1.  X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells.

Authors:  Susana S Silva; Rebecca K Rowntree; Shila Mekhoubad; Jeannie T Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-13       Impact factor: 11.205

2.  X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations.

Authors:  Yin Shen; Youko Matsuno; Shaun D Fouse; Nagesh Rao; Sierra Root; Renhe Xu; Matteo Pellegrini; Arthur D Riggs; Guoping Fan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-13       Impact factor: 11.205

3.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

Review 4.  Embryonic stem (ES) cells and embryonal carcinoma (EC) cells: opposite sides of the same coin.

Authors:  P W Andrews; M M Matin; A R Bahrami; I Damjanov; P Gokhale; J S Draper
Journal:  Biochem Soc Trans       Date:  2005-12       Impact factor: 5.407

5.  Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.

Authors:  Silvia M Sirchia; Lisetta Ramoscelli; Francesca R Grati; Floriana Barbera; Danila Coradini; Franca Rossella; Giovanni Porta; Elena Lesma; Anna Ruggeri; Paolo Radice; Giuseppe Simoni; Monica Miozzo
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

6.  X-inactivation status varies in human embryonic stem cell lines.

Authors:  Lisa M Hoffman; Lisa Hall; Jennifer L Batten; Holly Young; Dheerja Pardasani; E Edward Baetge; Jeanne Lawrence; Melissa K Carpenter
Journal:  Stem Cells       Date:  2005-08-25       Impact factor: 6.277

7.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

8.  Embryonic stem cell lines derived from human blastocysts.

Authors:  J A Thomson; J Itskovitz-Eldor; S S Shapiro; M A Waknitz; J J Swiergiel; V S Marshall; J M Jones
Journal:  Science       Date:  1998-11-06       Impact factor: 47.728

9.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

10.  Adaptation to culture of human embryonic stem cells and oncogenesis in vivo.

Authors:  Duncan E C Baker; Neil J Harrison; Edna Maltby; Kath Smith; Harry D Moore; Pamela J Shaw; Paul R Heath; Hazel Holden; Peter W Andrews
Journal:  Nat Biotechnol       Date:  2007-02       Impact factor: 54.908

View more
  8 in total

1.  Detection of nascent RNA, single-copy DNA and protein localization by immunoFISH in mouse germ cells and preimplantation embryos.

Authors:  Satoshi H Namekawa; Jeannie T Lee
Journal:  Nat Protoc       Date:  2011-02-10       Impact factor: 13.491

2.  Pregnancy-induced chromatin remodeling in the breast of postmenopausal women.

Authors:  Jose Russo; Julia Santucci-Pereira; Ricardo López de Cicco; Fathima Sheriff; Patricia A Russo; Suraj Peri; Michael Slifker; Eric Ross; Maria Luiza S Mello; Benedicto C Vidal; Ilana Belitskaya-Lévy; Alan Arslan; Anne Zeleniuch-Jacquotte; Pal Bordas; Per Lenner; Janet Ahman; Yelena Afanasyeva; Goran Hallmans; Paolo Toniolo; Irma H Russo
Journal:  Int J Cancer       Date:  2012-01-03       Impact factor: 7.396

3.  Xist deficiency and disorders of X-inactivation in rabbit embryonic stem cells can be rescued by transcription-factor-mediated conversion.

Authors:  Yonghua Jiang; Zhaohui Kou; Tong Wu; Weidong An; Ran Zhou; Hong Wang; Yawei Gao; Shaorong Gao
Journal:  Stem Cells Dev       Date:  2014-06-26       Impact factor: 3.272

4.  Erosion of dosage compensation impacts human iPSC disease modeling.

Authors:  Shila Mekhoubad; Christoph Bock; A Sophie de Boer; Evangelos Kiskinis; Alexander Meissner; Kevin Eggan
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

5.  Defining the genomic signature of the parous breast.

Authors:  Suraj Peri; Ricardo López de Cicco; Julia Santucci-Pereira; Michael Slifker; Eric A Ross; Irma H Russo; Patricia A Russo; Alan A Arslan; Ilana Belitskaya-Lévy; Anne Zeleniuch-Jacquotte; Pal Bordas; Per Lenner; Janet Åhman; Yelena Afanasyeva; Robert Johansson; Fathima Sheriff; Göran Hallmans; Paolo Toniolo; Jose Russo
Journal:  BMC Med Genomics       Date:  2012-10-11       Impact factor: 3.063

6.  Activity map of the tammar X chromosome shows that marsupial X inactivation is incomplete and escape is stochastic.

Authors:  Shafagh Al Nadaf; Paul D Waters; Edda Koina; Janine E Deakin; Kristen S Jordan; Jennifer Am Graves
Journal:  Genome Biol       Date:  2010-12-23       Impact factor: 13.583

7.  Variation in TAF1 expression in female carrier induced pluripotent stem cells and human brain ontogeny has implications for adult neostriatum vulnerability in X-linked Dystonia Parkinsonism.

Authors:  Laura D'Ignazio; Ricardo S Jacomini; Bareera Qamar; Kynon J M Benjamin; Ria Arora; Tomoyo Sawada; Taylor A Evans; Kenneth E Diffenderfer; Aimee R Pankonin; William T Hendriks; Thomas M Hyde; Joel E Kleinman; Daniel R Weinberger; D Cristopher Bragg; Apua C M Paquola; Jennifer A Erwin
Journal:  eNeuro       Date:  2022-07-21

8.  Loss of Xist RNA from the inactive X during B cell development is restored in a dynamic YY1-dependent two-step process in activated B cells.

Authors:  Camille M Syrett; Vishal Sindhava; Suchita Hodawadekar; Arpita Myles; Guanxiang Liang; Yue Zhang; Satabdi Nandi; Michael Cancro; Michael Atchison; Montserrat C Anguera
Journal:  PLoS Genet       Date:  2017-10-09       Impact factor: 5.917

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.